We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 25, 2021

Definitive Local Therapy in Select Patients With HER2+ de Novo Metastatic Breast Cancer Treated With Dual Anti-HER2 Blockade

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
Breast Cancer Res Treat 2021 Nov 17;[EPub Ahead of Print], L Rosier, Y Wang, JH Lee, K Daily

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading